Skye Bioscience Inc (SKYE)
13.42
+0.64
(+5.01%)
USD |
NASDAQ |
May 02, 12:13
Skye Bioscience Research and Development Expense (Quarterly): 1.592M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.592M |
| September 30, 2023 | 1.255M |
| June 30, 2023 | 1.788M |
| March 31, 2023 | 1.185M |
| December 31, 2022 | 1.537M |
| September 30, 2022 | 1.782M |
| June 30, 2022 | 1.427M |
| March 31, 2022 | 1.266M |
| December 31, 2021 | 1.113M |
| September 30, 2021 | 0.3277M |
| June 30, 2021 | 0.8807M |
| March 31, 2021 | 0.6097M |
| December 31, 2020 | 0.3701M |
| September 30, 2020 | 0.3462M |
| June 30, 2020 | 0.4285M |
| March 31, 2020 | 0.7996M |
| December 31, 2019 | 0.7159M |
| September 30, 2019 | 0.513M |
| June 30, 2019 | 0.688M |
| Date | Value |
|---|---|
| March 31, 2019 | 0.321M |
| December 31, 2018 | 0.2377M |
| September 30, 2018 | 0.0673M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.025M |
| December 31, 2017 | 0.07M |
| September 30, 2017 | 0.0886M |
| June 30, 2017 | 0.0607M |
| March 31, 2017 | 0.0921M |
| December 31, 2016 | 0.2632M |
| September 30, 2016 | 0.0805M |
| June 30, 2016 | 0.46M |
| March 31, 2016 | 0.1354M |
| December 31, 2015 | 0.3432M |
| September 30, 2015 | 0.1523M |
| June 30, 2015 | 0.0434M |
| March 31, 2015 | 0.0372M |
| December 31, 2014 | 0.0325M |
| September 30, 2014 | 0.195M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.3277M
Minimum
Sep 2021
1.788M
Maximum
Jun 2023
0.9802M
Average
0.8807M
Median
Jun 2021
Research and Development Expense (Quarterly) Benchmarks
| Cutera Inc | 4.564M |
| Medical Marijuana Inc | -- |
| OrthoPediatrics Corp | 2.747M |
| RAPT Therapeutics Inc | 26.76M |
| NovaBay Pharmaceuticals Inc | 0.004M |